3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Interventions
pembrolizumab
28
Paclitaxel
24
Carboplatin
19
Bevacizumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
Doxorubicin
8
Cisplatin
8
Biopsy
8
olaparib
7
lenvatinib
7
Taxes
7
Letrozole
7
Megestrol Acetate
6
Fulvestrant
6
durvalumab
5
dostarlimab
5
Nivolumab
5
Medroxyprogesterone Acetate
5
Gemcitabine
5
trastuzumab deruxtecan
4
abemaciclib
4
X-Rays
4
Trastuzumab
4
Tirzepatide
4
Progestins
4
Oxaliplatin
4
Immunoglobulin G
4
Fluorouracil
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
LY3023414
×
90 days
×
Clear all
No trials found.